Knowledge Hub

Rotavirus vaccination programs show significant short-term return on investments

In a UK cost-effectiveness analysis, which takes into account herd effect, the budget impact analysis demonstrated that the introduction of a rotavirus vaccine program could pay back between 58-96% of the cost outlay for the program within the first 4 years.

Full Citation:
Atkins, K.E., Carroll, S., et al.. 2012. The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.. Vaccine. 30(48).

Title of Article: The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales.

Author(s): Atkins, K.E., Carroll, S., et al.

Publication Year: 2012

Publication Name: Vaccine

Publication Volume: 30(48)

Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/23000223

DOI (Digital Object Identifier): 10.1016/j.vaccine.2012.09.025

Topics: Economics & Return on Investment

Disease Vaccines: Diarrhea | Rotavirus

Countries: England | Wales

WHO Regions: Europe